U.S Physical Therapy PE Ratio 2010-2023 | USPH

Current and historical p/e ratio for U.S Physical Therapy (USPH) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. U.S Physical Therapy PE ratio as of April 26, 2024 is 39.30.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

U.S Physical Therapy PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-04-26 100.61 74.53
2023-12-31 92.75 $1.35 68.71
2023-09-30 90.90 $1.72 52.85
2023-06-30 119.79 $1.93 62.07
2023-03-31 96.25 $2.16 44.56
2022-12-31 79.29 $2.25 35.24
2022-09-30 74.04 $2.99 24.76
2022-06-30 105.83 $2.93 36.12
2022-03-31 96.01 $2.88 33.34
2021-12-31 91.84 $2.42 37.95
2021-09-30 105.91 $2.37 44.69
2021-06-30 110.56 $2.32 47.66
2021-03-31 99.04 $2.49 39.77
2020-12-31 114.07 $2.83 40.31
2020-09-30 82.41 $2.81 29.33
2020-06-30 76.85 $3.05 25.20
2019-12-31 108.05 $2.45 44.10
2019-09-30 123.03 $2.33 52.80
2019-06-30 115.26 $1.87 61.63
2019-03-31 98.53 $1.15 85.68
2018-12-31 95.77 $1.24 77.24
2020-03-31 65.45 $1.08 60.60
2018-09-30 110.76 $1.45 76.39
2018-06-30 89.47 $1.73 51.72
2018-03-31 75.58 $1.64 46.09
2017-12-31 66.94 $1.75 38.25
2017-09-30 56.80 $1.66 34.22
2017-06-30 55.64 $1.71 32.54
2017-03-31 59.79 $1.89 31.63
2016-12-31 64.27 $1.94 33.13
2016-09-30 57.25 $1.94 29.51
2016-06-30 54.82 $1.95 28.11
2016-03-31 45.14 $1.89 23.89
2015-12-31 48.56 $1.80 26.98
2015-09-30 40.49 $1.73 23.40
2015-06-30 49.25 $1.69 29.14
2015-03-31 42.59 $1.71 24.91
2014-12-31 37.51 $1.72 21.81
2014-09-30 31.54 $1.63 19.35
2014-06-30 30.37 $1.22 24.89
2014-03-31 30.59 $1.10 27.80
2013-12-31 31.08 $1.06 29.32
2013-09-30 27.31 $1.08 25.29
2013-06-30 24.20 $1.44 16.81
2013-03-31 23.42 $1.44 16.26
2012-12-31 23.92 $1.82 13.14
2012-09-30 23.56 $1.82 12.94
2012-06-30 21.61 $1.85 11.68
2011-12-31 16.59 $1.75 9.48
2011-09-30 15.55 $1.41 11.03
2011-06-30 20.68 $1.45 14.26
2011-03-31 18.62 $1.37 13.59
2010-12-31 16.39 $1.44 11.38
2012-03-31 19.52 $1.36 14.35
2010-09-30 13.83 $1.17 11.82
2010-06-30 13.96 $1.10 12.69
2010-03-31 14.39 $1.03 13.97
2009-12-31 14.00 $0.99 14.14
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.516B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.392B 9.92
Quest Diagnostics (DGX) United States $14.915B 15.41
DaVita (DVA) United States $11.709B 15.93
Chemed (CHE) United States $8.472B 26.30
Encompass Health (EHC) United States $8.259B 21.25
Elanco Animal Health (ELAN) United States $6.552B 14.90
Option Care Health (OPCH) United States $5.147B 19.48
RadNet (RDNT) United States $3.314B 96.80
Amedisys (AMED) United States $2.999B 21.25
LifeStance Health (LFST) United States $2.370B 0.00
Astrana Health (ASTH) United States $2.057B 25.68
Addus HomeCare (ADUS) United States $1.548B 23.52
Pennant (PNTG) United States $0.624B 36.46
Aveanna Healthcare Holdings (AVAH) United States $0.423B 0.00
Atai Life Sciences (ATAI) Germany $0.323B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.029B 0.00
ATI Physical Therapy (ATIP) United States $0.018B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.014B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.005B 0.00